Triptolide may be used as a male contraceptive

Recently, the scientific research teams of Tang Yunge and Qin Weibing, the Key Laboratory of Male Reproduction and Genetics of the National Health Commission of Guangdong Province Family Planning Hospital (Guangdong Family Planning Science and Technology Institute), and the University of California team, are engaged in the research and development of non-hormonal male contraceptives.

It is understood that male contraceptive methods are currently limited to external ejaculation, sterilization and condoms, and the development of male contraceptives is very slow.

Qin Weibing introduced that as early as 2009, the research team put forward the idea of ​​using the haploid phase of spermatogenesis as a target for the development of male non-hormonal contraceptives.

In 2015, the Guangdong Provincial Family Planning Hospital and the University of California team began a five-year scientific research.

Qin Weibing said that the study also preliminarily explained its target of action and contraceptive mechanism, and believed that triptolide is a non-hormonal male contraceptive candidate with great transformative application prospects.